New Delhi, India; Mumbai, India 7/25/07—Indian news sources report that RFCL, an Indian supplier of laboratory products and services, has acquired Wipro Biomed, an OEM partner and distributor of research and clinical products, from software company Wipro. The transaction price was not disclosed. Wipro Biomed consists of three businesses: the Life Science Group, Diagnostic System […]
Waltham, MA 7/26/07—PerkinElmer has announced that Robert F. Friel, president of the company’s Life and Analytical Sciences division (LAS), will become president and COO, effective August 1. He is expected to be named CEO in February 2008, replacing Gregory L. Summe, who will become executive chairman until April 2009. The LAS presidency is not expected […]
CS Bio introduced the CS336 multichannel solid phase peptide synthesizer. 3-Prime launched the Retro-Columns synthesis columns, developed with DNA Technologies, for extending the lifespan of older synthesizers.
Under a collaboration and licensing agreement with Dr. Gerry Shaw of the University of Florida and EnCor Biotechnology, Millipore is developing a neurofilament ELISA kit to measure the biomarker pNF-H. Millipore named Charles Wagner, vice president of Strategy and Corporate Development, CFO, effective August 15. Meridian Bioscience restructured and expanded its Meridian Life Science subsidiary […]
According to the results of survey published in June by, the top three choices for outsourced R&D were other companies (48.1%), independent R&D organizations (38.9%) and academia (35.1%). The two most popular types of outsourced work were new product innovations (32.1%) and new process innovations (31.3%). The two most common reasons for outsourcing were the […]
Abingdon, UK 7/26/07—Oxford Instruments has agreed to acquire 81.4% of Worldwide Analytical Systems AG (WAS), a supplier of arc/spark optical emission spectrometers. Oxford Instruments will pay a maximum of £9.3 million ($19.1 million) in cash. Based in Uedem, Germany, with 67 employees, WAS generated 2006 revenues of £5.7 million ($10.5 million) and a profit of […]
Thermo Fisher Scientific has entered into an agreement to acquire India-based Qualigens Fine Chemicals from GlaxoSmithKline Pharmaceuticals for INR 240 crore ($59.5 million). According to Thermo, Qualigens is India’s largest laboratory chemical manufacturer and supplier. Based in Mumbai with 150 employees country-wide, Qualigen’s manufactures and sells fine chemicals, diagnostic kits and laboratory products, and had […]
IBO published its annual analytical and life science instrument industry forecast for 2007 in mid-January (see IBO 1/15/07). While we only had preliminary estimates of the industry’s 2006 performance, it was clear that the year was better than 2005. Still, a fair amount of uncertainty remained about our 2007 forecast, not the least being the […]
San Francisco’s Moscone Convention Center again hosted the 2007 Semicon West exposition, which ran July 16–20. Last year, IBO noted a certain levity among the booths and exhibits (see IBO 7/15/06), as spirits were doubtless buoyed by the surge of business in 2006. Indeed, sales of semiconductor equipment in 2006 surpassed even the generous growth […]
Late last week, PerkinElmer announced that Robert F. Friel, president of the company’s Life and Analytical Sciences division (LAS), would transition to president and COO on August 1, before being named CEO next February. Gregory L. Summe, chairman, president and CEO, who has been with the company 10 years as of next January, will assume […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
